Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionphosphatidylinositol-3,4-bisphosphate binding

MYO1G SESTD1 WASHC2C WASHC2A FCHSD2

6.26e-06351515GO:0043325
GeneOntologyMolecularFunctionuracil binding

DPYD DPYS

5.68e-0521512GO:0002058
GeneOntologyMolecularFunctionpyrimidine nucleobase binding

DPYD DPYS

5.68e-0521512GO:0002061
GeneOntologyMolecularFunctionphosphatidylinositol-3,5-bisphosphate binding

SESTD1 WASHC2C WASHC2A ATP13A2

8.43e-05311514GO:0080025
GeneOntologyMolecularFunctionphosphatidylinositol-3,4,5-trisphosphate binding

MYO1G WASHC2C WASHC2A FCHSD2

5.11e-04491514GO:0005547
GeneOntologyMolecularFunctionnucleobase binding

DPYD DPYS

5.60e-0451512GO:0002054
GeneOntologyMolecularFunctionphosphatidylinositol-5-phosphate binding

SESTD1 WASHC2C WASHC2A

6.72e-04231513GO:0010314
GeneOntologyBiologicalProcessregulation of actin nucleation

WASHC2C WHAMM CORO1B WASHC2A FCHSD2

1.19e-05411515GO:0051125
GeneOntologyBiologicalProcessArp2/3 complex-mediated actin nucleation

WASHC2C WHAMM CORO1B WASHC2A FCHSD2

2.36e-05471515GO:0034314
GeneOntologyBiologicalProcessuracil catabolic process

DPYD DPYS

5.32e-0521512GO:0006212
GeneOntologyBiologicalProcesspyrimidine ribonucleotide catabolic process

DPYD DPYS ENTPD4

6.08e-05111513GO:0009222
GeneOntologyBiologicalProcessregulation of Arp2/3 complex-mediated actin nucleation

WASHC2C CORO1B WASHC2A FCHSD2

7.45e-05311514GO:0034315
DomainMst1_SARAH_domain

STK3 STK4

6.07e-0521462IPR024205
DomainMst1_SARAH

STK3 STK4

6.07e-0521462PF11629
DomainFAM21

WASHC2C WASHC2A

6.07e-0521462IPR027308
DomainIGc2

PDGFRB SPEG NFASC SIRPB2 ADAMTSL3 PTPRF PTPRS ROBO1 IGSF1

9.84e-052351469SM00408
DomainIg_sub2

PDGFRB SPEG NFASC SIRPB2 ADAMTSL3 PTPRF PTPRS ROBO1 IGSF1

9.84e-052351469IPR003598
Domain-

CALR CANX

1.81e-04314622.10.250.10
DomainCAP-ZIP_m

WASHC2C WASHC2A

1.81e-0431462PF15255
DomainCALRETICULIN_REPEAT

CALR CANX

1.81e-0431462PS00805
DomainFAM21/CAPZIP

WASHC2C WASHC2A

1.81e-0431462IPR029341
Domainfn3

IL12RB2 SPEG NFASC PTPRF UMODL1 PTPRS ROBO1

2.87e-041621467PF00041
DomainFAM47

FAM47C FAM47B

3.60e-0441462PF14642
DomainCalret/calnex

CALR CANX

3.60e-0441462IPR001580
DomainCALRETICULIN_1

CALR CANX

3.60e-0441462PS00803
DomainCALRETICULIN_2

CALR CANX

3.60e-0441462PS00804
DomainCalret/calnex_CS

CALR CANX

3.60e-0441462IPR018124
DomainFAM47

FAM47C FAM47B

3.60e-0441462IPR032743
DomainCalreticulin

CALR CANX

3.60e-0441462PF00262
DomainWD40_repeat_dom

DMXL2 UBR4 CORO1B CFAP43 DENND3 SF3B3 TULP4 FBXW5 NSMAF

5.56e-042971469IPR017986
DomainCalreticulin/calnexin_P_dom

CALR CANX

5.98e-0451462IPR009033
DomainFN3

IL12RB2 SPEG NFASC PTPRF UMODL1 PTPRS ROBO1

6.37e-041851467SM00060
DomainIg_I-set

PDGFRB SPEG NFASC ADAMTSL3 PTPRF PTPRS ROBO1

7.45e-041901467IPR013098
DomainI-set

PDGFRB SPEG NFASC ADAMTSL3 PTPRF PTPRS ROBO1

7.45e-041901467PF07679
DomainFN3

IL12RB2 SPEG NFASC PTPRF UMODL1 PTPRS ROBO1

9.77e-041991467PS50853
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

USP36 IRF2BP2 CALR CANX LARS1 PRPF8 EEF1A1 EEF1A1P5 CCT6A MISP SF3B3 DST AHNAK EIF4A1 PRKDC MOV10

5.08e-104771551631300519
Pubmed

Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.

MYO1G IRF2BP2 DMXL2 CALR CANX UBR4 PPP6R1 DST EVA1A PRKDC HECTD1 BCL2L13

2.58e-083221551226514267
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

ZNF787 EP400 CALR UBR4 RANBP9 CHD7 PPP6R1 CORO1B WASHC2A MDN1 ANAPC2

6.31e-082821551123667531
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

NES SESTD1 DMXL2 BIN1 DNAJC13 SGIP1 CANX UBR4 RANBP9 NFASC CHD7 PPP6R1 CORO1B ATF6B EEF1A1 DST MDN1 PTPRS EIF4A1

6.63e-089631551928671696
Pubmed

Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.

STK3 STK4 YAP1

8.68e-083155322042863
Pubmed

Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation.

STK3 STK4 YAP1

8.68e-083155324881775
Pubmed

YAP Inhibition Restores Hepatocyte Differentiation in Advanced HCC, Leading to Tumor Regression.

STK3 STK4 YAP1

8.68e-083155325772357
Pubmed

Hippo kinases MST1 and MST2 control the differentiation of the epididymal initial segment via the MEK-ERK pathway.

STK3 STK4 YAP1

8.68e-083155332332916
Pubmed

Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.

STK3 STK4 YAP1

8.68e-083155328099921
Pubmed

USP45 and Spindly are part of the same complex implicated in cell migration.

DBF4B LARS1 CORO1B PRPF8 EEF1A1P5 FCHSD2 SF3B3 AHNAK EIF4A1 PRKDC

1.14e-072351551030258100
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

RAF1 HLA-A WWP2 CANX LARS1 RANBP9 PPP6R1 CORO1B PRPF8 EEF1A1 DNAH1 CCT6A SF3B3 TULP4 TSR1 YAP1 UCHL3 EIF4A1 PRKDC HECTD1 YTHDF3

1.83e-0712471552127684187
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

MPO WASHC2C CALR CANX PRPF8 WASHC2A CRY2 STK3 STK4 HAUS8 MISP SF3B3 TSR1 GORASP1 AHNAK EIF4A1 ANAPC2 PAFAH1B3 PRKDC MOV10

2.37e-0711551552020360068
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

WASHC2C EP400 UBR4 LARS1 PRPF8 CCT6A MDN1 TSR1 AHNAK EIF4A1 PRKDC

3.24e-073321551132786267
Pubmed

YAP regulates alveolar epithelial cell differentiation and AGER via NFIB/KLF5/NKX2-1.

STK3 STK4 YAP1

3.46e-074155334466790
Pubmed

Two-signal requirement for growth-promoting function of Yap in hepatocytes.

STK3 STK4 YAP1

3.46e-074155325667983
Pubmed

A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis.

STK3 STK4 YAP1

3.46e-074155333086070
Pubmed

LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.

CANX UBR4 OAS3 CORO1B PRPF8 EEF1A1 ZBP1 MDN1 PRKDC HECTD1 MOV10

4.60e-073441551130333137
Pubmed

Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.

SPEG UBR4 LARS1 CHD7 DNAH1 TULP4 TSR1 ANAPC2

4.65e-07153155810718198
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

RAF1 SESTD1 DNAJC13 CALR LARS1 RANBP9 CORO1B PRPF8 MMADHC PTOV1 STK3 XYLT2 STK4 HAUS8 SF3B3 YAP1 AHNAK CRNN MUC5AC MOV10 AGAP1

4.68e-0713211552127173435
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

RAF1 IRF2BP2 HLA-A CALR CANX UBR4 LARS1 RANBP9 OAS3 PPP6R1 CORO1B PRPF8 GEM ZBP1 CCT6A SF3B3 DST MDN1 AHNAK EIF4A1 PRKDC MOV10

4.74e-0714401552230833792
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

EP400 SPEG GRK6 UBR4 PPP6R1 CORO1B CFAP43 WASHC2A ATP13A2 DST MDN1 PTPRF TULP4 PTPRS RALGPS1 AHNAK PRKDC HECTD1 BCL2L13

5.41e-0711051551935748872
Pubmed

Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer.

STK3 STK4 YAP1 PRKDC

6.62e-0716155432730753
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

MPO USP36 NES DNAJC13 EP400 UBR4 LARS1 RANBP9 OAS3 CHD7 CORO1B PRPF8 STK4 CCT6A SF3B3 DST MDN1 AHNAK EIF4A1 PRKDC MOV10

6.88e-0713531552129467282
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

NES HLA-A EP400 CALR CANX GRK6 LARS1 PRPF8 EEF1A1 CCT6A SF3B3 DST MDN1 PTPRF AHNAK EIF4A1 PAFAH1B3 PRKDC

8.04e-0710241551824711643
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

USP36 EP400 LARS1 NFASC SF3B3 DST TSR1 ARHGAP31 RALGPS1 ANAPC2 IGSF1 AGAP1 ZNF646

8.07e-075291551314621295
Pubmed

Netrin-1 exerts oncogenic activities through enhancing Yes-associated protein stability.

STK3 STK4 YAP1

8.63e-075155326039999
Pubmed

Tubule-Specific Mst1/2 Deficiency Induces CKD via YAP and Non-YAP Mechanisms.

STK3 STK4 YAP1

8.63e-075155332253273
Pubmed

CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.

STK3 STK4 YAP1

8.63e-075155331857346
Pubmed

The scaffold protein CNK1 interacts with the tumor suppressor RASSF1A and augments RASSF1A-induced cell death.

RAF1 STK3 STK4

8.63e-075155315075335
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

RAF1 NES CALR CANX UBR4 LARS1 RANBP9 CORO1B PRPF8 EEF1A1 CCT6A SF3B3 DST MDN1 TSR1 AHNAK EIF4A1 PRKDC MOV10

9.67e-0711491551935446349
Pubmed

The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.

CALR CANX PRPF8 EEF1A1 EEF1A1P5 CCT6A SF3B3 AHNAK EIF4A1

1.38e-06239155926641092
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

NES CALR CANX UBR4 CHD7 PRPF8 DST MDN1 TSR1 AHNAK EIF4A1 PRKDC HECTD1 MOV10

1.50e-066531551422586326
Pubmed

Long-Term Exposure to Imatinib Mesylate Downregulates Hippo Pathway and Activates YAP in a Model of Chronic Myelogenous Leukemia.

STK3 STK4 YAP1

1.72e-066155328103766
Pubmed

Pulmonary pericytes regulate lung morphogenesis.

STK3 STK4 YAP1

1.72e-066155329934496
Pubmed

RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein.

RAF1 STK3 YAP1

1.72e-066155317889669
Pubmed

Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.

STK3 STK4 YAP1

1.72e-066155326389641
Pubmed

YAP determines the cell fate of injured mouse hepatocytes in vivo.

STK3 STK4 YAP1

1.72e-066155328681838
Pubmed

The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense.

STK3 STK4 YAP1

1.72e-066155323684612
Pubmed

Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.

STK3 STK4 YAP1

1.72e-066155325695629
Pubmed

Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.

HLA-A UBR4 LARS1 PPP6R1 STK3 STK4 MDN1 TSR1 AHNAK ROBO1 PRKDC

1.95e-063991551137536630
Pubmed

A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.

NES ZNF274 HLA-A CALR CANX UBR4 EEF1A1 MISP GORASP1 AHNAK EIF4A1 MOV10

2.94e-065031551236217030
Pubmed

A directed protein interaction network for investigating intracellular signal transduction.

MBTPS1 DNAJC13 CALR UBR4 RANBP9 PPP6R1 ATP13A2 EEF1A1 STK3 MOXD1 SF3B3 YAP1 GORASP1 UCHL3 EIF4A1 ANAPC2 FBXW5 AGAP1

2.98e-0611241551821900206
Pubmed

Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis.

STK3 STK4 YAP1

3.00e-067155337166104
Pubmed

Yap1 Regulates Multiple Steps of Chondrocyte Differentiation during Skeletal Development and Bone Repair.

STK3 STK4 YAP1

3.00e-067155326923596
Pubmed

Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma.

RAF1 STK3 YAP1

3.00e-067155336038253
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

HLA-A CANX LARS1 PRPF8 CCT6A MISP SF3B3 AHNAK PRKDC

3.53e-06268155933024031
Pubmed

RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.

DNAJC13 CALR CANX PRPF8 PDHX EEF1A1 SF3B3 PRKDC

3.74e-06202155824639526
Pubmed

A Stk4-Foxp3-NF-κB p65 transcriptional complex promotes Treg cell activation and homeostasis.

STK3 STK4 YAP1

4.78e-068155336149942
Pubmed

Yap1 acts downstream of α-catenin to control epidermal proliferation.

STK3 STK4 YAP1

4.78e-068155321376238
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SESTD1 DMXL2 BIN1 HLA-A PDGFRB UBR4 LARS1 DNER RANBP9 WHAMM PRPF8 EEF1A1 DST NECAB1 EIF4A1 ROBO1 PRKDC HECTD1 AGAP1

4.91e-0612851551935914814
Pubmed

Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.

RAF1 HLA-A CALR CANX LARS1 PRPF8 EEF1A1 CCT6A SF3B3 MDN1 TSR1 EIF4A1 PRKDC YTHDF3

5.01e-067251551427025967
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

ZNF787 DNAJC13 HLA-A CALR CANX UBR4 LARS1 CORO1B PRPF8 CCT6A MISP DST TSR1 AHNAK EIF4A1 ROBO1 PRKDC HECTD1 YTHDF3

5.61e-0612971551933545068
Pubmed

TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.

ZNF787 CALR CANX LARS1 PRPF8 EEF1A1 EEF1A1P5 CCT6A MISP SF3B3 DST TSR1 AHNAK EIF4A1 PRKDC MOV10

5.78e-069491551636574265
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

WASHC2C CALR LARS1 PRPF8 EEF1A1P5 CCT6A DST MDN1 TSR1 AHNAK EIF4A1 MOV10

5.83e-065381551228524877
Pubmed

Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity.

STK3 STK4 YAP1

7.15e-069155330413360
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

ENTPD4 RUSC2 MDN1 RALGPS1 IGSF1 ZNF646

7.53e-0610415569205841
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

CDCA3 BIN1 HLA-A WWP2 DST PTPRF ARHGAP31 PTPRS ROBO1 AGAP1

8.11e-063771551038117590
Pubmed

Aerobic glycolysis tunes YAP/TAZ transcriptional activity.

PRPF8 EEF1A1 EEF1A1P5 SF3B3 TSR1 YAP1 AHNAK

8.72e-06162155725796446
Pubmed

ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly.

HLA-A CALR CANX

1.02e-051015539545232
Pubmed

Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass.

STK3 STK4 YAP1

1.02e-0510155326378466
Pubmed

Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.

CALR PPM1D CANX UBR4 PPP6R1 PRPF8 CCT6A SF3B3 PTPRF GALNT9 PRKDC YTHDF3

1.09e-055731551228330616
Pubmed

Fgf10-Hippo Epithelial-Mesenchymal Crosstalk Maintains and Recruits Lung Basal Stem Cells.

STK3 STK4 YAP1

1.40e-0511155329017029
Pubmed

Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells.

STK3 STK4 YAP1

1.40e-0511155329849151
Pubmed

Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.

STK3 STK4 YAP1

1.40e-0511155328486106
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

CALR CANX UBR4 LARS1 PRPF8 EEF1A1 DNAH1 CCT6A SF3B3 DST MDN1 AHNAK EIF4A1 PRKDC

1.66e-058071551430575818
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

CANX LARS1 RANBP9 DHDDS SATL1 PRPF8 PDHX EEF1A1 CCT6A SF3B3 MDN1 TSR1 AHNAK PRKDC

1.71e-058091551432129710
Pubmed

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.

DNAJC13 CANX UBR4 OAS3 PRPF8 STK3 CCT6A SF3B3 TSR1 AHNAK EIF4A1 PRKDC

1.75e-056011551233658012
Pubmed

Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.

IRF2BP2 DPYD NUDT1 AGAP1

1.78e-0535155422688191
Pubmed

SLMAP3 is essential for neurulation through mechanisms involving cytoskeletal elements, ABP, and PCP.

NES STK3 STK4 YAP1

1.78e-0535155439366759
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

IRF2BP2 EP400 CALR CANX LARS1 CORO1B WASHC2A CCT6A SF3B3 DST EIF4A1

1.83e-055061551130890647
Pubmed

WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.

STK3 STK4 YAP1

1.85e-0512155335429439
Pubmed

Defining the membrane proteome of NK cells.

MYO1G DNAJC13 HLA-A PDGFRB CALR WWP2 CANX GRK6 UBR4 PRPF8 EEF1A1 TBC1D10C MDN1 AHNAK EIF4A1 PAFAH1B3 PRKDC

1.96e-0511681551719946888
Pubmed

C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.

RAF1 EEF1A1

1.97e-052155217332776
Pubmed

Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.

STK3 STK4

1.97e-052155234450249
Pubmed

MST1/2 in PDGFRα+ cells negatively regulates TGF-β-induced myofibroblast accumulation in renal fibrosis.

STK3 STK4

1.97e-052155235253468
Pubmed

Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin.

CALR CANX

1.97e-05215528550632
Pubmed

Localization dynamics of endogenous fluorescently labeled RAF1 in EGF-stimulated cells.

RAF1 EGF

1.97e-052155230586319
Pubmed

Inactivation of MST1/2 Controls Macrophage Polarization to Affect Macrophage-Related Disease via YAP and Non-YAP Mechanisms.

STK3 STK4

1.97e-052155238250155
Pubmed

Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum.

CALR CANX

1.97e-052155216467570
Pubmed

Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model.

EGF MUC5AC

1.97e-052155226057128
Pubmed

STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma.

STK3 STK4

1.97e-052155226457732
Pubmed

Calnexin, calreticulin and the folding of glycoproteins.

CALR CANX

1.97e-052155217708944
Pubmed

Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp).

WASHC2C WASHC2A

1.97e-052155220827171
Pubmed

Position- and polarity-dependent Hippo signaling regulates cell fates in preimplantation mouse embryos.

STK3 STK4

1.97e-052155225986053
Pubmed

Calreticulin is required for development of the cumulus oocyte complex and female fertility.

CALR CANX

1.97e-052155226388295
Pubmed

Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers.

STK3 STK4

1.97e-052155232510157
Pubmed

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

STK3 STK4

1.97e-052155219878874
Pubmed

FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans.

WASHC2C WASHC2A

1.97e-052155236717248
Pubmed

Enhanced clathrin-dependent endocytosis in the absence of calnexin.

SGIP1 CANX

1.97e-052155221747946
Pubmed

Hippo pathway regulation by cell morphology and stress fibers.

STK3 STK4

1.97e-052155221831922
Pubmed

Mammalian sterile 20 kinase 1 and 2 are important regulators of hematopoietic stem cells in stress condition.

STK3 STK4

1.97e-052155229343826
Pubmed

USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP.

USP36 YAP1

1.97e-052155236470870
Pubmed

Compromised calnexin function in calreticulin-deficient cells.

CALR CANX

1.97e-052155212727205
Pubmed

MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma.

RAF1 STK3

1.97e-052155228677804
Pubmed

Homozygous calreticulin mutations in patients with myelofibrosis lead to acquired myeloperoxidase deficiency.

MPO CALR

1.97e-052155227013444
Pubmed

Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control.

CALR CANX

1.97e-052155214731400
Pubmed

Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.

STK3 STK4

1.97e-052155219484742
Pubmed

Identification of a novel Rev-interacting cellular protein.

WASHC2C WASHC2A

1.97e-052155215847701
Pubmed

Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.

STK4 YAP1

1.97e-052155232376130
Pubmed

The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway.

YAP1 UCHL3

1.97e-052155236813921
InteractionMTNR1B interactions

IRF2BP2 DMXL2 CANX UBR4 PPP6R1 DST EVA1A PRKDC HECTD1 BCL2L13

6.87e-0813515010int:MTNR1B
InteractionPRRC2C interactions

USP36 RAF1 WWP2 CANX LARS1 EEF1A1 YAP1 AHNAK EIF4A1 HECTD1 YTHDF3 MOV10

1.85e-0629015012int:PRRC2C
InteractionMOB1B interactions

ZNF787 PPP6R1 STK3 STK4 DST ROBO1

2.96e-06541506int:MOB1B
InteractionPINK1 interactions

USP36 IRF2BP2 NES CALR CANX LARS1 PRPF8 EEF1A1 EEF1A1P5 CCT6A MISP SF3B3 DST YAP1 AHNAK EIF4A1 PRKDC MOV10

3.15e-0667915018int:PINK1
InteractionCAPN10 interactions

UBR4 STK3 STK4 CCT6A MISP

3.66e-06321505int:CAPN10
InteractionITGB3 interactions

RAF1 PDGFRB UBR4 OAS3 PRPF8 MDN1 PRKDC HECTD1 MOV10

5.25e-061701509int:ITGB3
InteractionSUMO2 interactions

USP36 WASHC2C EP400 CALR UBR4 LARS1 PRPF8 EEF1A1 CCT6A DST MDN1 TSR1 AHNAK EIF4A1 ANAPC2 PRKDC

8.87e-0659115016int:SUMO2
InteractionADAR interactions

USP36 RAF1 SESTD1 EP400 OAS3 EEF1A1 CRY2 SF3B3 YAP1 PRKDC HECTD1

1.01e-0528615011int:ADAR
InteractionRNF128 interactions

DNAJC13 HLA-A WWP2 CANX STK3 PTPRF

1.06e-05671506int:RNF128
InteractionEEF2 interactions

USP36 RAF1 BIN1 ISYNA1 CALR WWP2 CANX LARS1 PRPF8 EEF1A1 CRY2 YAP1 AHNAK EIF4A1 HECTD1

3.41e-0558815015int:EEF2
InteractionPDGFRB interactions

CDCA3 RAF1 HLA-A PDGFRB CANX UBR4 DST PTPRS PRKDC

5.41e-052281509int:PDGFRB
InteractionTMPRSS11B interactions

CDCA3 HLA-A ADAMTS2 CALR CANX UBR4 LARS1 ST3GAL2 PDHX PTPRF PRKDC YTHDF3

6.79e-0541615012int:TMPRSS11B
InteractionMYCBP2 interactions

RAF1 NES UBR4 CORO1B ATP13A2 CRY2 STK3 DST MDN1 EIF4A1 HECTD1

7.30e-0535515011int:MYCBP2
InteractionSLITRK6 interactions

STK3 STK4 SLITRK6

8.46e-05121503int:SLITRK6
InteractionRASSF6 interactions

STK3 STK4 HECTD1

8.46e-05121503int:RASSF6
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

PDGFRB SPEG NFASC ADAMTSL3 PTPRF PTPRS ROBO1

1.81e-05161927593
GeneFamilyWASH complex

WASHC2C WASHC2A

3.79e-0469221331
GeneFamilyWD repeat domain containing

DMXL2 CORO1B CFAP43 DENND3 TULP4 FBXW5 NSMAF

3.80e-04262927362
GeneFamilyFibronectin type III domain containing

IL12RB2 NFASC PTPRF PTPRS ROBO1

1.35e-03160925555
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CASS4 SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 MOXD1 DST PTPRS ROBO1

2.25e-0920015510e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

USP36 MYO1G BIN1 GRK6 CHD7 CORO1B TBC1D10C AHNAK SYTL1

2.92e-081951559e06ff785c5542c86c335d956799e03f7ae8345a4
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

CASS4 SGIP1 ADAMTS2 PDGFRB NFASC MOXD1 DST PTPRS ROBO1

2.92e-08195155961c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CASS4 SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 MOXD1 DST PTPRS

3.63e-082001559cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CASS4 SGIP1 ADAMTS2 NFASC ADAMTSL3 MOXD1 DST PTPRS ROBO1

3.63e-08200155934f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CASS4 SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 MOXD1 DST PTPRS

3.63e-082001559311fab076f2ceb258e3970eb21e39344b894042a
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ADAMTS2 NFASC GEM MOXD1 MDN1 ROBO1 MMP19

3.53e-071901558048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ADAMTS2 NFASC GEM MOXD1 MDN1 ROBO1 MMP19

3.53e-0719015581121eb607a984c59fbffe7220837fc178745aa55
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SGIP1 ADAMTS2 NFASC ADAMTSL3 MOXD1 DST PTPRS ROBO1

3.68e-0719115586688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SGIP1 ADAMTS2 NFASC ADAMTSL3 MOXD1 DST PTPRS ROBO1

3.83e-07192155899ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor

CASS4 SGIP1 ADAMTS2 PDGFRB NFASC MOXD1 PTPRS ROBO1

3.98e-071931558ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCellControl-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations)

SGIP1 ADAMTS2 PDGFRB NFASC GEM MOXD1 DST ROBO1

4.14e-07194155803a269f75a481ea54aea8e6444605db8d6df493d
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

SGIP1 ADAMTS2 NFASC ADAMTSL3 MOXD1 DST PTPRS ROBO1

4.30e-071951558aa0add081881d349099d12efca5cdee098038d4e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ADAMTS2 PDGFRB NFASC GEM MOXD1 ROBO1 MMP19

4.65e-0719715589b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCellCOVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations)

SGIP1 PDGFRB GEM MOXD1 DST PTPRS YAP1 ROBO1

4.65e-071971558fb847f2277609c31fffcdf49517243ce0684facf
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 MOXD1 PTPRS ROBO1

4.83e-07198155826e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ADAMTS2 NFASC GEM MOXD1 MDN1 ROBO1 MMP19

4.83e-071981558a860246bcea847249a78fd2e86ed8e04371060db
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

SGIP1 ADAMTS2 PDGFRB GEM MOXD1 DST PTPRS ROBO1

4.83e-071981558df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellCOVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

SGIP1 ADAMTS2 PDGFRB GEM MOXD1 DST PTPRS ROBO1

4.83e-0719815583ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 DST PTPRS ROBO1

4.83e-0719815588f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

SGIP1 ADAMTS2 PDGFRB ADAMTSL3 MOXD1 DST PTPRS ROBO1

5.02e-0719915584bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 MOXD1 DST PTPRS

5.21e-072001558389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SGIP1 ADAMTS2 PDGFRB ADAMTSL3 MOXD1 DST PTPRS ROBO1

5.21e-072001558cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CDCA3 ISYNA1 GRK6 ST3GAL2 GLIPR1L2 ROBO1 AGAP1

2.54e-0617315575295ed31648abf8edff214cf67cd4769f20f9e6d
ToppCellCV-Severe-7|CV / Virus stimulation, Condition and Cluster

IL12RB2 MBTPS1 HLA-A CALR CANX CHD7 DST

2.84e-0617615573de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

IL12RB2 MBTPS1 DNAJC13 HLA-A CANX CHD7 DST

2.95e-06177155782fdd6185b368f54f03de389427cbe3071d21a99
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFHR1 ADAMTS2 PDGFRB NFASC GEM MOXD1 MMP19

3.42e-061811557c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFHR1 ADAMTS2 PDGFRB NFASC GEM MOXD1 MMP19

3.42e-061811557c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

SGIP1 ADAMTS2 NFASC ADAMTSL3 DST PTPRS ROBO1

4.24e-06187155792d468dde81125d51daf7abd4703741abe1ab91c
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

SGIP1 ADAMTS2 NFASC ADAMTSL3 MOXD1 DST ROBO1

4.71e-0619015573a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

CASS4 SGIP1 ADAMTS2 MOXD1 DST PTPRS ROBO1

5.22e-06193155799525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

CASS4 SGIP1 ADAMTS2 NFASC ADAMTSL3 DST PTPRS

5.22e-061931557b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

CASS4 SGIP1 ADAMTS2 MOXD1 DST PTPRS ROBO1

5.22e-061931557acad568621ed677031797b8c2e34dafea798d681
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYO1G HLA-A STK4 TBC1D10C ZBP1 PIM1 SYTL1

5.22e-061931557c7aeb7001d4be0a7c3269d939ec84d8c6d15e0c9
ToppCellCerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Cerebellum / BrainAtlas - Mouse McCarroll V32

MISP MOXD1 GBGT1 SYTL1 MMP19 MOV10

5.31e-06126155683f3540683b3b175b10af059ab8898c46eaccc13
ToppCellCerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)|Cerebellum / BrainAtlas - Mouse McCarroll V32

MISP MOXD1 GBGT1 SYTL1 MMP19 MOV10

5.31e-0612615566d5075d659dac7b96e6857f8485a7d2c4105d685
ToppCellCerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-|Cerebellum / BrainAtlas - Mouse McCarroll V32

MISP MOXD1 GBGT1 SYTL1 MMP19 MOV10

5.31e-061261556fd0001a0f3a0a4421f96fd21813c21cf6f01d40e
ToppCellCerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1|Cerebellum / BrainAtlas - Mouse McCarroll V32

MISP MOXD1 GBGT1 SYTL1 MMP19 MOV10

5.31e-061261556f20424f9baf3c4059cd6b701761e7595400fc47c
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

SGIP1 NFASC MOXD1 DST PTPRS YAP1 ROBO1

5.58e-061951557603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

SGIP1 ADAMTS2 PDGFRB ADAMTSL3 MOXD1 DST PTPRS

5.77e-061961557bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCellCOVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class

MPO DNAJC13 WASHC2C ADAMTS2 WASHC2A PIM1 AHNAK

5.77e-061961557f245e929a286cb097130572e1027b4f01be8b04d
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SGIP1 ADAMTS2 NFASC ADAMTSL3 DST PTPRS ROBO1

5.77e-0619615577d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

SGIP1 PDGFRB GEM MOXD1 DST YAP1 ROBO1

5.97e-061971557f1c8936986123a3151140c374fcd62d6705c530b
ToppCellPBMC|World / Compartment, Disease Groups and Clusters

ZNF787 IRF2BP2 BIN1 NUDT1 AHNAK EIF4A1 SYTL1

6.17e-06198155784f5b43dad0c57556171dbc0b799735654582ecf
ToppCell343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells)

CASS4 SGIP1 ADAMTS2 PDGFRB MOXD1 DST PTPRS

6.37e-0619915579c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCellCOVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type

SGIP1 ADAMTS2 PDGFRB NFASC GEM MOXD1 DST

6.37e-0619915579503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells)

CASS4 SGIP1 ADAMTS2 PDGFRB MOXD1 DST PTPRS

6.37e-061991557f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCellParenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

CASS4 PDGFRB NFASC GEM MOXD1 DST PTPRS

6.59e-062001557aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

CASS4 PDGFRB NFASC GEM MOXD1 DST PTPRS

6.59e-062001557a510deaada669e690329183e18df02870bd204b3
ToppCellproximal-3-Epithelial-Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ISYNA1 RASSF10 EEF1A1 DST PIM1 SLITRK6 SYTL1

6.59e-0620015578083047c213488e40b975013e3c5c43f7c0c15b2
ToppCellproximal-Epithelial-Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ISYNA1 RASSF10 EEF1A1 DST PIM1 SLITRK6 SYTL1

6.59e-062001557f5d48f521abbd1e07de05f2b3768ad2f9675f1e1
ToppCellproximal-Epithelial-Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

ISYNA1 RASSF10 EEF1A1 DST PIM1 SLITRK6 SYTL1

6.59e-062001557c6a491d3e2dae6618f25dc3c9aac08f657348168
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CASS4 PDGFRB NFASC GEM MOXD1 DST PTPRS

6.59e-062001557dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MPO MYO1G DENND3 UMODL1 SYTL1 PRL

1.87e-051571556d12f343454202da86a06d0369f8ffe5662cd091b
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ISYNA1 PDGFRB SPEG PERM1 NFASC MUC5AC

2.47e-0516515568a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCellPosterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

CDCA3 GAL3ST1 RASSF10 CHD7 CCT6A SLITRK6

2.56e-051661556a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

CDCA3 DBF4B OAS3 PPP6R1 HAUS8 ROBO1

2.73e-051681556ca94b29c1030484143a77f2df06dad74d2c6136e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES PDGFRB NFASC DST NECAB1 ROBO1

3.12e-0517215566c17a1e586a72d1bd80c20c06370429c61dc9f85
ToppCellLPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO1G IL12RB2 TBC1D10C ZBP1 GLIPR1L2 SYTL1

3.22e-051731556fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAF1 DBF4B PAIP2B C2orf81 DENND3 STK3

3.22e-05173155662abaaaf48cabd1423f17fb27c33b75ea88867f4
ToppCellLPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

MYO1G IL12RB2 TBC1D10C ZBP1 GLIPR1L2 SYTL1

3.22e-051731556dcde3252ff96448d3a61039a4948c74ad321a218
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ISYNA1 PDGFRB SPEG PERM1 NFASC MUC5AC

3.22e-0517315565416b092321c7d9b63f0418c60f2402a138355bf
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells)

MYO1G HLA-A GRK6 STK4 TBC1D10C SYTL1

3.22e-051731556b06d6e7acb7086bb99600b680cf404c0ef06b52c
ToppCell5'-Adult-Distal_Rectal-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RAF1 DBF4B PAIP2B C2orf81 DENND3 STK3

3.22e-05173155609cd878c33534bd476d6a4880f5582076189da8c
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFHR1 PDGFRB NFASC GEM DNAH1 MOXD1

3.55e-051761556b4a23d8d1414434adeb237a96f28c825f1aebd77
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CFHR1 PDGFRB NFASC GEM DNAH1 MOXD1

3.55e-05176155666c9c6b59030f67e8d746a9c6930e50923f2ded1
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GRK6 EEF1A1 TBC1D10C MISP UCHL3 PAFAH1B3

3.78e-0517815569b932b677ae05ac6e12cd6ce97789f8c10e4790b
ToppCelldroplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BIN1 GRK6 EEF1A1 TBC1D10C FCHSD2 PAFAH1B3

4.02e-051801556b51b10781082bc0305ba6a81e978729b329f7771
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PDGFRB DNER NFASC ADAMTSL3 MOXD1 P2RY1

4.28e-0518215563dfa9187e9d2bab1d199079d29209c4648220ada
ToppCellLV-07._Pericyte|World / Chamber and Cluster_Paper

ISYNA1 PDGFRB NFASC ADAMTSL3 DENND3 ADORA2A-AS1

4.41e-051831556273db6a3b00a93ca852498471187b642b5368185
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES SGIP1 PDGFRB NFASC DST NECAB1

4.69e-0518515569197f074e769d54031ec41abfc65fcc0c6552c7e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES SGIP1 PDGFRB NFASC DST NECAB1

4.69e-051851556ce7d62394b09c26ca65b8cdb280afec5e25bbb62
ToppCellhuman_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 GEM

4.83e-051861556cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SGIP1 ADAMTS2 PDGFRB EVA1A ROBO1 MMP19

4.83e-051861556f07e0c0d9c80ac9d8d679950e7d0c812becb85a3
ToppCellCOVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

SGIP1 ADAMTS2 PDGFRB NFASC GEM MOXD1

4.97e-05187155676bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CHD7 SF3B3 TSR1 AHNAK GDPGP1 MUC5AC

4.97e-051871556f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

IL12RB2 BIN1 ISYNA1 PDGFRB EEF1A1 UMODL1

5.12e-0518815560a47de24812c619f6756c9351a413b109128d54f
ToppCellnormal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass

NES ISYNA1 PDGFRB SPEG NFASC GEM

5.12e-051881556fd70fb89570f014d1299c60fe017dc09f24e57c6
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SH2D3A DNER DST EGF YAP1 HECTD1

5.28e-051891556e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYO1G DPYD DMXL2 ADAMTS2 LRG1 AHNAK

5.28e-05189155655aba1ebc012006a5db3ff9c92589cb3d9f7c68a
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ADAMTS2 PDGFRB NFASC MOXD1 ROBO1

5.28e-051891556c734e5693808a0333139e87bd5be2597a9252afe
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NES HLA-A PDGFRB CALR NFASC NECAB1

5.43e-05190155692710caaff05123cf8e909319d7ac441d9b31a66
ToppCellILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CDCA3 ADAMTS2 DBF4B YAP1 SLITRK6 AGAP1

5.43e-05190155639fa110d19c97c7cac99f5fb91b26bc08e2f3b42
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYO1G BIN1 HLA-A STK4 TBC1D10C ZBP1

5.59e-051911556753deb090b7b78b4ef31604dbe5dbfc4dcf5184a
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 PDGFRB NFASC MOXD1 DST ROBO1

5.59e-051911556c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYO1G BIN1 HLA-A STK4 TBC1D10C ZBP1

5.59e-051911556337d7d7b89fe370e1fe005b9daad76c5dc3b8444
ToppCellhuman_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)

SGIP1 ADAMTS2 PDGFRB NFASC ADAMTSL3 GEM

5.59e-05191155678c3c2fdb68c3407f2436f90e1e6a780bbf8b79e
ToppCell5'-Adult-LymphNode-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IL12RB2 DPYD ZNF274 WHAMM SF3B3 BCL2L13

5.59e-051911556e5c41c3054ead03597c136eaccaf9822e6bb9d1a
ToppCell3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYO1G BIN1 HLA-A STK4 TBC1D10C ZBP1

5.59e-051911556355f5bcb220d917163833dead0050fc756c7b260
ToppCell5'-Adult-LymphNode-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

IL12RB2 DPYD ZNF274 WHAMM SF3B3 BCL2L13

5.59e-0519115567e24175c7fabe5ea0b22b73173da4c3a666e5eb8
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 ADAMTS2 PDGFRB NFASC MOXD1 DST

5.59e-051911556806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 PDGFRB NFASC MOXD1 DST ROBO1

5.59e-051911556cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 PDGFRB SPEG NFASC GEM MOXD1

5.59e-05191155604c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SGIP1 PDGFRB NFASC GEM MOXD1 MMP19

5.76e-0519215564022f208eb5db760abd0aac782a25e8ab63efc64
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS2 PDGFRB NFASC ADAMTSL3 GEM MOXD1

5.76e-051921556bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CRY2 DST TULP4 P2RY1 ROBO1 SLITRK6

5.76e-0519215565b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS2 PDGFRB NFASC ADAMTSL3 MOXD1 ROBO1

5.76e-0519215565105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCelldroplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF2BP2 CALR UBR4 PTOV1 DST PTPRF

5.76e-0519215560dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCelldroplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IRF2BP2 CALR CANX CRY2 PTOV1 DST

5.76e-0519215564510aa262da8dcf7c944b3907a51aba5a9397a4e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ADAMTS2 PDGFRB NFASC ADAMTSL3 GEM MOXD1

5.76e-0519215560ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
DrugSanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A

EP400 UBR4 PAIP2B PEX26 CRY2 STK4 SF3B3 PTPRF TULP4 AHNAK PRKDC

7.69e-08191154114168_DN
Diseasegallbladder cancer (is_marker_for)

DPYD CALR EGF

4.18e-0671473DOID:3121 (is_marker_for)
DiseaseDihydropyrimidinuria

DPYD DPYS

2.47e-0521472C3495551
Diseasedevelopmental and epileptic encephalopathy 33 (implicated_via_orthology)

EEF1A1 EEF1A1P5

7.37e-0531472DOID:0080463 (implicated_via_orthology)
DiseaseMyopathy, Centronuclear, Autosomal Recessive

BIN1 SPEG

1.47e-0441472C0410204
Diseaseras-related protein Rab-26 measurement

MPO HLA-A

2.44e-0451472EFO_0801989
Diseaseantiphospholipid antibody measurement

SESTD1 SGIP1 EVA1A

2.57e-04251473EFO_0005200
Diseaseazoospermia (implicated_via_orthology)

ISYNA1 PTPRF PTPRS

3.25e-04271473DOID:14227 (implicated_via_orthology)
Diseaseventral diencephalon volume measurement

CORO1B GALNT9

5.09e-0471472EFO_0010337
Diseasesystemic scleroderma

IL12RB2 CHD7 TULP4 ARHGAP31

8.75e-04851474EFO_0000717
DiseaseDystonia

PDGFRB ATP13A2 MMADHC PDHX

9.15e-04861474C0013421
Diseasepeptidyl-glycine alpha-amidating monooxygenase measurement

GIN1 GRK6

1.32e-03111472EFO_0801871
Diseasehousehold income, smoking status measurement, educational attainment, protein intake measurement, carbohydrate intake measurement, alcohol consumption measurement, physical activity measurement, body mass index, energy intake measurement

ZNF787 C1orf94

1.32e-03111472EFO_0004340, EFO_0006527, EFO_0007878, EFO_0008002, EFO_0009374, EFO_0009695, EFO_0010810, EFO_0010811, EFO_0011015
DiseaseGastric Adenocarcinoma

PDGFRB SPEG GRK6

1.47e-03451473C0278701
DiseaseLenticulostriate Disorders

PDGFRB PRL

1.57e-03121472C0750951
DiseaseExtrapyramidal Disorders

PDGFRB PRL

1.57e-03121472C0015371
DiseaseMyoinositol measurement

ZP2 GALNT9

1.57e-03121472EFO_0021652
DiseaseBasal Ganglia Diseases

PDGFRB PRL

1.57e-03121472C0004782
Diseasefructose measurement

UBR4 P2RY1

1.85e-03131472EFO_0010477
DiseaseDEAFNESS, AUTOSOMAL RECESSIVE (disorder)

DMXL2 PDZD7

1.85e-03131472C1846647
DiseaseParanoid Schizophrenia

HLA-A CALR

1.85e-03131472C0036349
DiseaseAutistic Disorder

DPYD HLA-A EGF ROBO1 PRL AGAP1

2.02e-032611476C0004352
Diseasecancer (implicated_via_orthology)

RAF1 DHDDS STK3 STK4 DST YAP1

2.31e-032681476DOID:162 (implicated_via_orthology)
DiseaseX-12063 measurement

BIN1 CRADD ADAMTS2 GEM NECAB1

2.45e-031861475EFO_0021283
DiseaseAutosomal Recessive Centronuclear Myopathy

BIN1 SPEG

2.48e-03151472C3645536
Diseasehousehold income, smoking status measurement, educational attainment, protein intake measurement, carbohydrate intake measurement, alcohol consumption measurement, body mass index, energy intake measurement

ZNF787 C1orf94

2.83e-03161472EFO_0004340, EFO_0006527, EFO_0007878, EFO_0009374, EFO_0009695, EFO_0010810, EFO_0010811, EFO_0011015
Diseasebasophil count

MPO MYO1G HLA-A DHDDS VWA7 EEF1A1P5 PRKDC NSMAF

2.99e-034831478EFO_0005090
Diseasehealth study participation

IRF2BP2 VWA7 PTPRF AGAP1 ZNF646

3.00e-031951475EFO_0010130
Diseasesystemic lupus erythematosus, COVID-19

IL12RB2 OAS3 GBGT1

3.06e-03581473MONDO_0007915, MONDO_0100096
Diseaselate-onset Alzheimers disease

CASS4 SESTD1 BIN1 C9orf152 PTPRS AHNAK

3.52e-032921476EFO_1001870
Diseasepancreatic ductal carcinoma (is_marker_for)

CALR EGF MUC5AC

3.53e-03611473DOID:3587 (is_marker_for)
Diseasemonocyte percentage of leukocytes

MPO MYO1G BIN1 HLA-A PDGFRB CHD7 EEF1A1P5 EGF AHNAK PRKDC

3.73e-0373114710EFO_0007989
Diseaseneutrophil count

MPO MYO1G NES BIN1 DNAJC13 SGIP1 WASHC2C HLA-A CANX DHDDS CHD7 VWA7 OSCP1 PRKDC BCL2L13

3.85e-03138214715EFO_0004833
Diseaseurate measurement, bone density

DNER ENTPD4 DNAH1 C9orf152 YAP1 GALNT9 GLIPR1L2 ROBO1 PRKDC

3.96e-036191479EFO_0003923, EFO_0004531
Diseaserenovascular hypertension (biomarker_via_orthology)

MPO PRL

3.99e-03191472DOID:1591 (biomarker_via_orthology)
Diseasecarcinoma (implicated_via_orthology)

STK3 STK4 YAP1

4.04e-03641473DOID:305 (implicated_via_orthology)
DiseaseDisorder of eye

SLC24A5 DHDDS PDZD7 PRPF8 ATP13A2

4.28e-032121475C0015397
Diseaseneutrophil count, eosinophil count

MPO MYO1G HLA-A CHD7 BCL2L13

4.36e-032131475EFO_0004833, EFO_0004842
Diseaseprostate adenocarcinoma (is_implicated_in)

RAF1 BIN1

4.42e-03201472DOID:2526 (is_implicated_in)
DiseaseInfiltrating duct carcinoma of female breast

PDGFRB GRK6

4.86e-03211472C3165106

Protein segments in the cluster

PeptideGeneStartEntry
EQELQGNSIMEPPSW

UMODL1

631

Q5DID0
LNTGEPMVAAEVGVW

CCT6A

481

P40227
NPEGPLLQGMEAADW

nan

11

A8MU10
LGPESWQQIAMDPEE

BCL2L13

271

Q9BXK5
EDVDGQTEVMPLWTP

EP400

2236

Q96L91
DNISNMPEGLDPLVW

CFAP43

1356

Q8NDM7
IQGTPVESDEMRPCW

NUDT1

91

P36639
PNWDMRDGFDISGNP

LRG1

286

P02750
GGPPEAQFAMWVDAV

AGAP1

126

Q9UPQ3
MSVWLQQGVLREEPP

ANAPC2

696

Q9UJX6
MRSWAEGPQPPTAQV

CASS4

116

Q9NQ75
MEQDWQPGEEVTPGP

ADORA2A-AS1

1

P86434
TVMVWQIPENGLTSP

CORO1B

106

Q9BR76
DVSAPDVEMQGPDWN

AHNAK

981

Q09666
MDIDAPDVEVQGPDW

AHNAK

1236

Q09666
FNRWGLPEVDPETMQ

DPYD

456

Q12882
MIPAIQRGDPQWSEL

DMXL2

1616

Q8TDJ6
QPWTSMEQLSVPVVG

C1orf94

81

Q6P1W5
MENNEETRPVLGWIP

C7orf31

516

Q8N865
ESMSAPEWEGAEQAP

DENND3

601

A2RUS2
PNTPDENDGSDIWMT

CC2D2B

1156

Q6DHV5
SSSMWGPRAVQVPDQ

CHD7

141

Q9P2D1
PNARLVAPGATMEWQ

ADAMTS2

126

O95450
LGTQLSVEEQMPPWN

CDCA3

126

Q99618
GNTPAPAESMVNAVW

C9orf152

66

Q5JTZ5
QVEQPTGSVLWMAPE

RAF1

501

P04049
FPIGDREGEWQTMIQ

RANBP9

356

Q96S59
REPGPQACADMWVDQ

RASSF10

456

A6NK89
DWFIPSRDLPQAMGQ

PAIP2B

71

Q9ULR5
QPGADQRGLVWPGMD

QRICH2

446

Q9H0J4
VSIVGWMVQLPDDPE

RALGPS1

491

Q5JS13
IREIWMNGQPEVPGT

EVA1A

131

Q9H8M9
GTVGMQPQQQRWSIP

GEM

11

P55040
VLPMVAPNDLVFDGW

ISYNA1

126

Q9NPH2
PTPVQDVQGDGRWMS

PAFAH1B3

11

Q15102
PPVDTQNWVFVTEGM

FAM47C

41

Q5HY64
VWPDETMGPFGPQDQ

MMADHC

56

Q9H3L0
MGPEASGWGQDEPQT

MISP

36

Q8IVT2
MTEVLWPAVPNGTDA

P2RY1

1

P47900
PADEVNMPHQWVEGN

DGKK

391

Q5KSL6
QLEMWQPRESGNPEE

MDN1

5291

Q9NU22
WMPDTGGANIPALNE

MBTPS1

746

Q14703
IGENMWVGPENEFTA

GLIPR1L2

116

Q4G1C9
ENTGMWLLPVRPQEG

DST

1731

Q03001
WNIPMSNPGVDFGDV

GALNT9

416

Q9HCQ5
PNGVNGVEDRMSVIW

DPYS

346

Q14117
RWQEMPGFGIQLVPE

FER1L4

1431

A9Z1Z3
SEGMDNILVTWQPPR

IL12RB2

431

Q99665
RSWPPNIVGMEEERN

ARNTL2

321

Q8WYA1
EPPGIADMWDVRSTN

DSG4

531

Q86SJ6
SRAWPNGAVVADPMQ

FBXW5

421

Q969U6
GMEPEGVIESNWNEI

EIF4A1

16

P60842
PNQPSAAMSWQDGRV

MMP19

426

Q99542
KQMPDVNVSWDGEGP

PDHX

341

O00330
PGWGRADTAMQTEPD

PDZD7

361

Q9H5P4
TPNNIDIWMGGVSEP

MPO

636

P05164
MQEPGAVLDVVGAWL

PEX26

131

Q7Z412
PPVDTQNWVFVTEGM

FAM47B

41

Q8NA70
QAPLWTPEEINQGAM

NES

846

P48681
LMAEGIQWPRNAPGI

GDPGP1

36

Q6ZNW5
SEMSGLWNVSIPDQP

MUC5AC

5086

P98088
QWAEVAQMPEGDLPQ

ANKRD65

366

E5RJM6
LGSDGLWNMIPPQDA

PPM1D

311

O15297
LQPDGRIMWQETGQT

MPND

106

Q8N594
QEVWEETQGMAPPSR

HAUS8

331

Q9BT25
PGSGQRWMQVSNPEA

CRNN

381

Q9UBG3
RWMQVSNPEAGETVP

CRNN

386

Q9UBG3
EVEVVPSNMWGGQGL

GORASP1

81

Q9BQQ3
TTMIVQWEEPVEPNG

PTPRS

441

Q13332
SGVMEWQEPRPEPNS

PTOV1

261

Q86YD1
PTVQWMVNGEPLQSA

NFASC

366

O94856
AIQDEAMQPWQPLGT

GAL3ST1

356

Q99999
GGSISIMTENPAPDW

DNAH1

3551

Q9P2D7
RMSVVVAWPGATQPE

ATP13A2

636

Q9NQ11
PDTLLEWLQMGQGDE

HECTD1

6

Q9ULT8
EPSSVVPMGQNVTLW

IGSF1

976

Q8N6C5
DRMEGNPICIQIPWD

CRY2

326

Q49AN0
DVDMVFRNPWGPETL

GBGT1

206

Q8N5D6
AADGSMQPTSWRQEP

EGF

1121

P01133
QRWTESLDGVMGPPA

DBF4B

406

Q8NFT6
DPRSGNMVEWCLPQD

DENND11

86

A4D1U4
VPISGWNGDNMLEPS

EEF1A1

191

P68104
NQLAQRLGPEWEPMV

CRADD

121

P78560
EMDGEWEPPVIQNPE

CALR

256

P27797
MDGEWEAPQIANPRC

CANX

346

P27824
MATEQWFEGSLPLDP

C19orf67

1

A6NJJ6
AQGMDGWRPLQSIPQ

DNAJC13

1011

O75165
SQRMEPRAPWIEQEG

HLA-A

66

P04439
PEPVMVTWDTGSLNG

IGHE

36

P01854
VPISGWNGDNMLEPS

EEF1A1P5

191

Q5VTE0
GQMVDDVELPPWASS

NSMAF

471

Q92636
GSQEQMESWEPSPQL

C2orf81

171

A6NN90
ENGDTPWMREIQISP

FCHSD2

631

O94868
EEVMCLNGNWTEPPQ

CFHR1

186

Q03591
TGNCPIPWQEEMIET

GRK1

511

Q15835
SVPIPWQNEMVETEC

GRK6

506

P43250
PFQNPEEQDEGWLMG

BIN1

551

O00499
ATGWTESMAPRQLQP

DNER

141

Q8NFT8
VREMAWGVEQGLLDP

DHDDS

166

Q86SQ9
PLVGSNVPWAFMQGE

IRF2BP2

556

Q7Z5L9
AAAGQDPAGVQWPDM

PERM1

601

Q5SV97
GSAPVVWERMSQEPP

PDGFRB

56

P09619
TPAQQQEEPEMLWVT

PTPRF

1251

P10586
QEEPEMLWVTGPVLA

PTPRF

1256

P10586
SRDGTSVQPWDVMPA

OAS3

731

Q9Y6K5
DWGELPNGTRVPMEV

PIM1

76

P11309
PVWSGLPSLQMADEE

PRL

176

P01236
NMPWSVVEASTQLGP

RUSC2

1066

Q8N2Y8
GLQVPWMDSTPEEKQ

SYTL1

521

Q8IYJ3
LSNGMEEIVNPENVW

TDRD6

2061

O60522
TWLENMPPQSIIGDV

SLITRK6

231

Q9H5Y7
ESVPMTWDPVDQNPR

MOV10

361

Q9HCE1
PETMFGQTNCWVRPD

LARS1

296

Q9P2J5
MNASWPVAGPVNEVL

LARS1

881

Q9P2J5
LWMEEGLPAQNAPGT

ENTPD4

601

Q9Y227
VENPWSLVTVDLMGP

GIN1

136

Q9NXP7
QPDTWQLGRSQPGML

SATL1

76

Q86VE3
GNISPVWTRENMDLP

ST3GAL2

91

Q16842
MEDEQPDSLEGWVPV

WHAMM

1

Q8TF30
VPWGTEVPGLIRMFN

OSCP1

206

Q8WVF1
RPQNPELSVDVWAGM

SLC39A5

96

Q6ZMH5
GVSWSPMDDELLAQP

SESTD1

231

Q86VW0
VMQVVNWLEGPGSEQ

SESTD1

281

Q86VW0
WDVPAPSLGAVQISM

ATF6B

211

Q99941
EMEPLGWIHTQPNES

PRPF8

2171

Q6P2Q9
PMLGEDVWVPQERTA

TULP4

1126

Q9NRJ4
RNDWQVLQPEGPMLV

SIRPB2

36

Q5JXA9
MEGQRWLPLEANPEV

UCHL3

1

P15374
LGEAAWSTAGDQPMP

YTHDF3

71

Q7Z739
VIGTPFWMAPEVIQE

STK3

181

Q13188
QWEDPRTQGMIQEPA

WWP2

431

O00308
MESPRGWTLQVAPEE

ZNF497

1

Q6ZNH5
QAEVIPDPMEGEQTW

TSR1

356

Q2NL82
VDPWGPQDIHMEQSI

ZBP1

246

Q9H171
AEWSIQGMTALPPDI

MOXD1

556

Q6UVY6
GAATPMDWQEQGRAP

SPEG

1966

Q15772
PEIWGSGQPINPSME

SGIP1

221

Q9BQI5
MQVPQDGEDLAGQPW

SH2D3A

1

Q9BRG2
ELAEAPGDPQWMETI

TBC1D10C

121

Q8IV04
WMSEEEVLPAGQPAE

ZNF274

241

Q96GC6
PLPDGWEQAMTQDGE

YAP1

231

P46937
QEPRWEEKGMPTTNG

ZNF646

321

O15015
RSEQQPLMGWEDEGQ

SLC24A5

241

Q71RS6
EDMSVPRGPIAQWAD

WASHC2C

1036

Q9Y4E1
LTKQEGEWGQEGMPP

ARHGAP31

391

Q2M1Z3
VSWQPPPEDTQNGMV

ROBO1

796

Q9Y6N7
EMAVSELPGNPNAVW

SF3B3

446

Q15393
AMVAWVTQEPPDSGE

PPP6R1

56

Q9UPN7
QENGDEAPGVWMIPT

PRKDC

591

P78527
TEDMSVPRGPIAQWA

WASHC2A

1056

Q641Q2
GTPFWMAPEVIQEIG

STK4

186

Q13043
GDLIVWSDEMNPPQV

UBR4

1296

Q5T4S7
TMDDPPQTGTWEIQV

VWA7

571

Q9Y334
MDPDSFPQWNVVVDG

ZP2

551

Q05996
IQWDESQAQQPMDGP

XYLT2

216

Q9H1B5
QPSAQGPAETLEMWL

XYLT2

611

Q9H1B5
RMGLSQAPPVSWNGE

USP36

1006

Q9P275
WNPVEGILPSGMVTF

TMEM260

491

Q9NX78
EAWSPGPLDSEDQQM

ZNF787

6

Q6DD87
MQWRGIQEETPPAAQ

ADAMTSL3

1136

P82987
GPEGQLVSWIVMEQS

GLYATL2

206

Q8WU03
MEVPTAIWNGGQDIV

LIPK

331

Q5VXJ0
TDPTLRAMWPDGQQD

MYO1G

551

B0I1T2
NVSGPGLLEEDNQWM

NECAB1

201

Q8N987